FADS1/2-mediated lipid metabolic reprogramming drives ferroptosis sensitivity in triple-negative breast cancer https://www.biorxiv.org/content/10.1101/2023.06.30.547227v1?med=mas
FADS1/2-mediated lipid metabolic reprogramming drives ferroptosis sensitivity in triple-negative breast cancer https://www.biorxiv.org/content/10.1101/2023.06.30.547227v1?med=mas